RBC Capital Reiterates Outperform on Outset Medical, Maintains $29 Price Target
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Shagun Singh has reiterated an Outperform rating on Outset Medical (NASDAQ:OM) and maintained a $29 price target.
August 17, 2023 | 2:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Outset Medical's stock rating has been reiterated as Outperform by RBC Capital, with a maintained price target of $29.
The reiteration of an Outperform rating by RBC Capital indicates a positive outlook for Outset Medical. The maintained price target of $29 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100